Advisory Research Inc. reduced its holdings in TriMas Corp (NASDAQ:TRS) by 5.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,346,940 shares of the industrial products company’s stock after selling 76,944 shares during the quarter. Advisory Research Inc. owned 2.95% of TriMas worth $36,031,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Great West Life Assurance Co. Can increased its position in shares of TriMas by 114.4% during the 3rd quarter. Great West Life Assurance Co. Can now owns 6,790 shares of the industrial products company’s stock valued at $183,000 after purchasing an additional 3,623 shares during the period. First Quadrant L P CA acquired a new position in shares of TriMas during the 4th quarter valued at $195,000. Cigna Investments Inc. New acquired a new position in shares of TriMas during the 4th quarter valued at $212,000. Thompson Siegel & Walmsley LLC acquired a new position in shares of TriMas during the 3rd quarter valued at $227,000. Finally, SG Americas Securities LLC acquired a new position in shares of TriMas during the 3rd quarter valued at $228,000. Hedge funds and other institutional investors own 98.04% of the company’s stock.
TRS has been the topic of several research analyst reports. BidaskClub cut TriMas from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, October 31st. ValuEngine raised TriMas from a “hold” rating to a “buy” rating in a research note on Sunday, December 31st. Deutsche Bank set a $29.00 price objective on TriMas and gave the stock a “hold” rating in a research note on Friday, January 19th. Finally, Zacks Investment Research raised TriMas from a “hold” rating to a “buy” rating and set a $31.00 price objective for the company in a research note on Monday, January 22nd. One research analyst has rated the stock with a sell rating, four have issued a hold rating and three have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $26.83.
Shares of TriMas Corp (NASDAQ TRS) opened at $22.95 on Thursday. The firm has a market capitalization of $1,063.02, a price-to-earnings ratio of 16.73, a PEG ratio of 2.92 and a beta of 1.94. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.33 and a current ratio of 2.67. TriMas Corp has a one year low of $19.75 and a one year high of $28.85.
In other news, insider Joshua A. Sherbin sold 13,828 shares of the firm’s stock in a transaction on Monday, November 20th. The stock was sold at an average price of $25.50, for a total value of $352,614.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Robert J. Zalupski sold 2,816 shares of the firm’s stock in a transaction on Thursday, November 30th. The stock was sold at an average price of $25.94, for a total value of $73,047.04. The disclosure for this sale can be found here. Company insiders own 1.40% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Advisory Research Inc. Has $36.03 Million Position in TriMas Corp (TRS)” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this story on another site, it was illegally stolen and reposted in violation of international copyright legislation. The legal version of this story can be viewed at https://www.dispatchtribunal.com/2018/02/15/advisory-research-inc-has-36-03-million-position-in-trimas-corp-trs.html.
TriMas Corporation is a designer, manufacturer and distributor of engineered products for commercial, industrial and consumer markets. The Company operates through four segments: Packaging, Aerospace, Energy and Engineered Components. The Packaging segment is a designer, manufacturer and distributor of engineered closure and dispensing systems for a range of end markets, including steel and plastic industrial, and consumer packaging applications.
Want to see what other hedge funds are holding TRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TriMas Corp (NASDAQ:TRS).
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.